Order Careers Contact Us Sign in Adaptive Biotechnologies Order Careers
Contact Us Sign in Immune Profiling Platform Platform OverviewPublications
Products & Services LIFE SCIENCES RESEARCHimmunoSEQ®CLINICAL
DIAGNOSTICSclonoSEQ®PipelineDRUG DISCOVERYCellular TherapyVaccines
PARTNERSHIPS Cancer Cellular TherapyAntigen MapBiopharma PartnershipsStrategic
Collaborators About Us Our StoryCultureCareersNewsroomContact Us Puget Sound
Business Journal: Adaptive Biotechnologies raises $105M 04/08/2010 Seattle
research company Adaptive Biotechnologies, which was spun off from the Fred
Hutchison Cancer Research Center, said it’s raised $105 million in funding
from Viking Global Investors. GO TO ARTICLE Previous News Feature Adaptive
TCR, a Fred Hutch Spinoff, nabs $4.5M to uncover Immune System Secrets.
03/26/2010 Next News Feature CNN: Differences found in individuals’ immune
systems 09/01/2010 Corporate/Research (855) 466-8667 Diagnostics (888)
522-8988 Immune Profiling PlatformPlatform Overview Publications Products &
ServicesLIFE SCIENCES RESEARCH immunoSEQ® CLINICAL DIAGNOSTICS clonoSEQ®
Pipeline DRUG DISCOVERY Cellular Therapy Vaccines PartnershipsCancer Cellular
Therapy Antigen Map Biopharma Partnerships Strategic Collaborators About UsOur
Story Culture Careers News & Events Contact Us © Adaptive Biotechnologies. All
Rights Reserved. Terms of Use Online Privacy Policy Privacy Shield Policy
HIPAA Policy Code of Conduct Patents & Trademarks Licenses